Skip to Content Skip to Content

Health Sciences

Reset All Filters
2002 Results
Combination Therapy Shows Promise for Rare, Deadly Cancer Caused by Asbestos, Penn Study Shows

Combination Therapy Shows Promise for Rare, Deadly Cancer Caused by Asbestos, Penn Study Shows

Pleural mesothelioma patients who undergo lung-sparing surgery in combination with photodynamic therapy (PDT) show superior overall survival than patient treated using the conventional therapy of extrapleural pneumonectomy (EPP) (or en bloc removal of the lung and surrounding tissue) with PDT, indicates new research from the Raymond and Ruth Perelman

Jessica Mikulski

Penn Announces Partnership With Chinese Academy of Sciences for Center of Excellence in Brain Mapping

Penn Announces Partnership With Chinese Academy of Sciences for Center of Excellence in Brain Mapping

BEIJING, CHINA –- In a ceremony today, the University of Pennsylvania (Penn) announced a collaboration agreement with the Chinese Academy of Sciences (CAS) to develop a joint Center of Excellence in Brain Mapping for the purpose of collaborative research and education in neuroimaging.

Jacquie Posey , Laura Cavender

Stay fit and social with Penn’s Walking Program

Stay fit and social with Penn’s Walking Program

Exercising is always more fun with a buddy who can provide encouragement and support. The Penn Walking Program pushes staff and faculty to get active by giving walkers motivational tools, offering walking companions and supplying some free goodies to get you started.

Jeanne Leong

Penn's Neurodegenerative Disease Research Center Collaborates to Improve Alzheimer's Monitoring

Penn's Neurodegenerative Disease Research Center Collaborates to Improve Alzheimer's Monitoring

Penn's Center for Neurodegenerative Disease Research (CNDR) will partner with Johnson & Johnson Pharmaceutical Research and Development, L.L.C., (J&JPRD) to develop algorithms that can identify changes in biomarkers related to disease diagnosis and for monitoring disease progression.

Kim Menard

Penn: No Increase in Severe Cardiovascular Events for Children, Adolescents on ADHD Medications

Penn: No Increase in Severe Cardiovascular Events for Children, Adolescents on ADHD Medications

Despite recent concerns that medications for attention deficit hyperactivity disorder (ADHD) could increase the risk of cardiovascular events in children and adolescents, an observational study conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania and HealthCore Inc.

Karen Kreeger